Toggle light / dark theme

Christian Schafmeister, Ph.D., Professor at Temple University in Philadelphia says: “We are developing “therapeutic catalysts” — small, robust, non-immunogentic catalysts that will permeate the tight spaces within tissues and fix things. Our specific targets include reversing the unwanted cross-links that develop in the extracellular matrix with aging.”

Enzymes, while possessing exquisite substrate-specificity, are limited by their molecular size in their ability to gain access to their substrate when it is embedded within dense material. We have always known that this may be a problem for our approach to restoring the elasticity of aged tissues. Christian’s fascinating work offers the potential to solve this issue with molecules that have the same catalytic function as enzymes but are much smaller and can therefore reach these embedded substrates.

Popular Science discusses the Harold space warping project at NASA and Quantum Vacuum Plasma Thruster

Quantum Vacuum Plasma Thruster

White shows me into the facility and ushers me past its central feature, something he calls a quantum vacuum plasma thruster (QVPT). The device looks like a large red velvet doughnut with wires tightly wound around a core, and it’s one of two initiatives Eagleworks is pursuing, along with warp drive. It’s also secret. When I ask about it, White tells me he can’t disclose anything other than that the technology is further along than warp drive … Yet when I ask how it would create the negative energy necessary to warp space-time he becomes evasive.

In this data article, we provide five datasets of mantis mitochondrial genomes: PCG123: nucleotide sequences of 13 protein-coding genes including all codon positions; PCG123R: nucleotide sequences of two rRNAs and 13 protein-coding genes including all codon positions; PCG12: nucleotide sequences of 13 protein-coding genes without third codon positions; PCG12R: nucleotide sequences of two rRNAs and 13 protein-coding genes without third codon positions, and PCGAA: amino acid sequences of 13 protein-coding genes. These were used to construct phylogenetic relationships within Mantodea and the phylogenetic trees inferred from Bayesian analysis using two data sets (PCG12R, PCGAA) and Maximum Likelihood analysis using four data sets (PCG123, PCG12, PCG12R and PCGAA). We also provide initiation codon, termination codon, amino acid length and nucleotide diversity (Pi) of protein-coding genes among 27 mantises. The whole mitochondrial genomes of 27 praying mantises were submitted to GenBank with the accession numbers KY689112 KY689138.

Molecule Rules

The team even managed to observe two of three atoms collide to form a molecule — a process that has never been observed on this scale before. They were surprised at how long it took compared to previous experiments and calculations.

“By working at this molecular level, we now know more about how atoms collide and react with one another,” lead author and postdoc researcher Marvin Weyland said in a statement. “With development, this technique could provide a way to build and control single molecules of particular chemicals.”

It is in this second phase when Darwinian evolutionary rivers will merge with the rivers of intelligent designers, represented by scientists, programmers and engineers, who will fuse organic natural biology, synthetic biology, and digital technology into a unified whole that future generations will deem their anatomy. The merger will serve to afford greater intelligence and, longer, healthier lives. In exchange, we will relinquish actual autonomy for apparent autonomy, where what was once considered “free will” will be supplanted by the deterministic logic of machinery somewhere in the mainstream of our unconscious.

Although in-the-body technology will have an explosive effect on commerce, entertainment, and employment, in the near term the concentration will be on medical devices, such as the innocuous pacemaker (essentially a working silicon-based computer, with sensors, memories, and a stimulation device with telecommunications to the outer world). In a second epoch, these devices will be gradually down-sized by advances in synthetic DNA, molecular- and nano-sized processors, each deployed alongside and within cells and organs as permanent non-organic, internal adjuncts to our anatomy for use as: nano-prosthetics, nano-stimulators/suppressors, artificial organ processors, metabolic and cognitive enhancers, and permanent diagnostic tools to ensure our physical and psychological well-being as we head toward a practically interminable lifetime.[6]

Will a wide-spread practice of installing technology into the body fundamentally change human essence? Our sense of self-sufficiency, authenticity, or individual identity? Will it change that numerical identity, the one “I” as some static aspect of ourselves (as self-consciousness as idealized by Locke)? Or will it change our narrative identity, our unseen internal human form, to eventually redefine what it means to be human?[7].

Had a very frank discussion with Greg Mustreader about transhumanism, learned helplessness of society in the face of aging and death, insufficient sense of urgency among researchers of aging, epigenetic rejuvenation, cryonics, and so on. No filter! 😁.


My blog on Medium: https://medium.com/@mustreader

My Twitter: https://twitter.com/mustreader